Last reviewed · How we verify
NCT03581357
Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors
NA trial testing Mobile Mindfulness Meditation in Cancer, Other Than Non-melanoma Skin Cancer in 302 participants. Completed in 11 July 2023.
11 July 2023
Quick facts
| Lead sponsor | University of Hawaii |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 302 |
| Start date | 3 April 2019 |
| Primary completion | 11 July 2023 |
| Estimated completion | 11 July 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Mobile Mindfulness Meditation
- Mindfulness Coach
Conditions studied
- Cancer, Other Than Non-melanoma Skin Cancer — all drugs for Cancer, Other Than Non-melanoma Skin Cancer →
Sponsor
University of Hawaii
Who can join
21 and older, any sex, with Cancer, Other Than Non-melanoma Skin Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluate the impact and satisfaction of Mobile Mindfulness Meditation on anxiety, pain, fatigue, trauma, and sleep in cancer survivors.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Recruiting Cancer Survivors to a Mobile Mindfulness Intervention in the United States: Exploring Online and Face-to-Face Recruitment Strategies.
Arnobit CI, Loo K, Pagano I, Uchiyama M, et al · · 2021 · cited 7× · PMID 34639439 · DOI 10.3390/ijerph181910136 -
OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysis.
Xu Q, Liu Y, Sun D, Huang X, et al · · 2023 · cited 3× · PMID 37935585 · DOI 10.1093/database/baad077 -
Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial.
Orasud AS, Uchiyama M, Pagano I, Bantum E. · · 2024 · PMID 38345843 · DOI 10.2196/47745 -
OMM: Online Mobile Mindfulness to Improve the Well-Being of Cancer Survivors
Orasud AS, Bantum E, Uchiyama M. · · 2022 · DOI 10.21203/rs.3.rs-2074085/v1
Verify or expand the search:
- PubMed search for NCT03581357
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Hawaii trials
Trials by the same sponsor.
- NCT06964633 — The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men. · NA · not yet recruiting
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT07075575 — Quit-Smoking Study for Native Hawaiians · NA · not yet recruiting
- NCT07075120 — Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer · Phase 1 · not yet recruiting
- NCT06978790 — Generative Artificial Intelligence Nurse Staffing Study · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03581357 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Hawaii
- Last refreshed: 24 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03581357.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing